Cannabis For Pets

Beverly Isla on Pet Life Radio

With medical marijuana making headway into North America's medical system, the research into pet benefits is also coming into full spectrum. This show features the work of Drs. Sarah Brandon and Greg Copas who are considered leaders in the research and product effectiveness for animal cannabis science. Their latest formulation Canna Companion is the world's premier site for cannabis/hemp education and products for the pet world. We will go over not only how it can benefit issues common to rescue dogs but pets in general. 

BIO:

Dr. Sarah Brandon

Sarah graduated from Oklahoma State University’s College of Veterinary Medicine in 2002 and is a co-founder/owner and operator of Canna Companion LLC based in Sultan Washington. For the past 12 years, Sarah practiced feline-only medicine and is the co-creator of the Company’s Canna Companion product line. In addition to being one of the world leaders in the investigation of Cannabis Science and its potential to compliment traditional veterinary medicine, Sarah possesses a strong business acumen, razor sharp presentation skills and significant media savvy. That combined with her natural ability as a tier one administrator and her outside the box approach to holistic and traditional veterinary medicine have proven to be and will continue to be invaluable assets in guiding, directing and expanding the Canna Companion product line to the forefront of this emerging sector.

Dr. Greg Copas

Greg also graduated from Oklahoma State University’s College of Veterinary Medicine in 2002 and is also a co-founder/owner and operator of Canna Companion LLC. Greg practiced in veterinary emergency medicine and surgery. Greg is also the co-creator of the Company’s Canna Companion product line and his obvious highly focused passion is in the field of research, development and clinical study. In fact, the genesis of the current formulations began with Greg’s personal investigation into the therapeutic applications of cannabis over 15 years ago and the migration to the application for animals followed soon after. His fastidious attention to detail and tireless work ethic represents the foundation of the Company’s R&D division going forward. He is currently exploring a wide range of additional OTC product possibilities and prescription grade applications for the veterinary industry as well.